Acur?cia das medidas de imped?ncia respirat?ria para o diagn?stico de asma em crian?as

Detalhes bibliográficos
Ano de defesa: 2019
Autor(a) principal: Fernandes, Morgana Tha?s Carollo lattes
Orientador(a): Jones, Marcus Herbert lattes
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Pontif?cia Universidade Cat?lica do Rio Grande do Sul
Programa de Pós-Graduação: Programa de P?s-Gradua??o em Medicina/Pediatria e Sa?de da Crian?a
Departamento: Escola de Medicina
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://tede2.pucrs.br/tede2/handle/tede/9081
Resumo: Introduction: Detecting airway changes is very important for treatment and diagnosis of asthmatic children. For the efficient and cost-effective adoption of treatment options directed at daily clinical practice, reliable and well-defined biomarkers contribute to the identification of asthma phenotypes and endotypes that are most likely to respond. In this scenario, the forced oscillation technique (FOT) is a promising method in the diagnosis and monitoring of respiratory diseases. Objective: To evidence forced oscillation technique (FOT) parameters that may be used as biomarkers for the diagnosis and monitoring of asthma. Methods: cross-sectional observational study with a quantitative approach. The sample consisted of children and adolescents with asthma and healthy controls, aged 3 to 17 years old, recruited from the S?o Lucas Hospital of the Pontifical Catholic University of Rio Grande do Sul (PUCRS). The anthropometry, clinical history and respiratory impedance measurements were obtained in all participants. The Research Ethics Committee of the educational institution under opinion No. 3,100,553 approved the project and informed consent was obtained from all participants and their guardians. Results: A total of 101 individuals (61 males) were recruited, 38 with asthma (Asthma group) and 63 healthy controls (Control group). Pre-bronchodilator spectral measurements showed that all variables had significant differences (p <0.001), with higher resistance and lower (negative) reactance in the asthmatic group. In the within-breath analysis, we observed that in the measurements taken before bronchodilator administration, the differences were significant between the two groups, with p?0.001 in all comparisons except in the difference between mean inspiratory resistance and expiration (dRmean). The accuracy of resistance measures to discriminate asthma was 0.94 for ReE, 0.89 for ReI and 0.76 for ReE-ReI and for reactance was 0.91 for XeE, 0.91 for XeI and 0.79 to XeE-XeI. Correcting estimates of accuracy, sensitivity, specificity, and area under the curve by confounders (stature) on the ROC curve did not change the results. Conclusions: The data obtained suggest that within-breath FOT measurements have excellent discriminatory power for asthma in children and adolescents. Measurement of impedance may aid in the diagnosis of asthma, may also assess the effect of treatment on pulmonary function, and may be used alone or as a complementary method to spirometry. In our sample, the resistance measures had the best discrimination performance.
id P_RS_fcd2caea3174c70905ae27810ffb415b
oai_identifier_str oai:tede2.pucrs.br:tede/9081
network_acronym_str P_RS
network_name_str Biblioteca Digital de Teses e Dissertações da PUC_RS
repository_id_str
spelling Jones, Marcus Herberthttp://lattes.cnpq.br/2057491798074403http://lattes.cnpq.br/7890106575135063Fernandes, Morgana Tha?s Carollo2020-01-31T12:32:59Z2019-08-30http://tede2.pucrs.br/tede2/handle/tede/9081Introduction: Detecting airway changes is very important for treatment and diagnosis of asthmatic children. For the efficient and cost-effective adoption of treatment options directed at daily clinical practice, reliable and well-defined biomarkers contribute to the identification of asthma phenotypes and endotypes that are most likely to respond. In this scenario, the forced oscillation technique (FOT) is a promising method in the diagnosis and monitoring of respiratory diseases. Objective: To evidence forced oscillation technique (FOT) parameters that may be used as biomarkers for the diagnosis and monitoring of asthma. Methods: cross-sectional observational study with a quantitative approach. The sample consisted of children and adolescents with asthma and healthy controls, aged 3 to 17 years old, recruited from the S?o Lucas Hospital of the Pontifical Catholic University of Rio Grande do Sul (PUCRS). The anthropometry, clinical history and respiratory impedance measurements were obtained in all participants. The Research Ethics Committee of the educational institution under opinion No. 3,100,553 approved the project and informed consent was obtained from all participants and their guardians. Results: A total of 101 individuals (61 males) were recruited, 38 with asthma (Asthma group) and 63 healthy controls (Control group). Pre-bronchodilator spectral measurements showed that all variables had significant differences (p <0.001), with higher resistance and lower (negative) reactance in the asthmatic group. In the within-breath analysis, we observed that in the measurements taken before bronchodilator administration, the differences were significant between the two groups, with p?0.001 in all comparisons except in the difference between mean inspiratory resistance and expiration (dRmean). The accuracy of resistance measures to discriminate asthma was 0.94 for ReE, 0.89 for ReI and 0.76 for ReE-ReI and for reactance was 0.91 for XeE, 0.91 for XeI and 0.79 to XeE-XeI. Correcting estimates of accuracy, sensitivity, specificity, and area under the curve by confounders (stature) on the ROC curve did not change the results. Conclusions: The data obtained suggest that within-breath FOT measurements have excellent discriminatory power for asthma in children and adolescents. Measurement of impedance may aid in the diagnosis of asthma, may also assess the effect of treatment on pulmonary function, and may be used alone or as a complementary method to spirometry. In our sample, the resistance measures had the best discrimination performance.Introdu??o: Detectar altera??es das vias a?reas ? muito importante para o manejo e diagn?stico de crian?as asm?ticas. Para a ado??o eficiente e custo-efetivo de op??es de tratamento direcionadas ? pr?tica cl?nica di?ria, biomarcadores confi?veis e bem definidos contribuem na identifica??o de fen?tipos e endotipos de asma com maior probabilidade de resposta. Nesse cen?rio, a t?cnica de oscila??es for?adas (FOT) ? um m?todo promissor na monitoriza??o e diagn?stico de doen?as respirat?rias. Objetivo: evidenciar par?metros da t?cnica de oscila??es for?adas (FOT) que possam ser utilizados como biomarcadores para o diagn?stico e monitoramento da asma. M?todos: estudo transversal, observacional com abordagem quantitativa. A amostra foi composta por crian?as e adolescentes com asma e controles saud?veis, entre 3 e 17 anos de idade, recrutados no Hospital S?o Lucas da Pontif?cia Universidade Cat?lica do Rio Grande do Sul (PUCRS). A antropometria, hist?ria cl?nica e medidas da imped?ncia respirat?ria foram obtidas em todos os participantes. O projeto foi aprovado pelo Comit? de ?tica em Pesquisa da institui??o de ensino sob parecer n?: 3.100.553 e o consentimento informado foi obtido de todos os participantes e seus respons?veis. Resultados: Foram recrutados 101 indiv?duos (61 do sexo masculino), sendo 38 portadores de asma (grupo Asma) e 63 controles sadios (grupo Controle). Nas medidas espectrais pr? broncodilatador observou-se que todas as vari?veis apresentam diferen?as significativas (p<0,001), com resist?ncia mais alta e a reat?ncia mais baixa (negativa) no grupo de asm?ticos. Na an?lise within-breath observou-se que nas medidas realizadas antes da administra??o do broncodilatador as diferen?as s?o significativas entre os dois grupos, com p?0,001 em todas as compara??es exceto na diferen?a entre a resist?ncia m?dia da inspira??o e a expira??o (dRmean). A acur?cia das medidas de resist?ncia para discriminar asma foi de 0,94 para ReE, 0,89 para ReI e 0,76 para ReE-ReI e para reat?ncia foi de 0,91 para XeE, 0,91 para XeI e 0,79 para XeE-XeI. A corre??o das estimativas de acur?cia, sensibilidade, especificidade e ?rea sob a curva por confundidores (estatura) na curva ROC n?o modificou os resultados. Conclus?es: os dados obtidos sugerem que as medidas de FOT within-breath tem excelente poder discriminat?rio para asma em crian?as e adolescentes. A medida da imped?ncia pode ajudar no diagn?stico de asma e tamb?m avaliar o efeito do tratamento na fun??o pulmonar, podendo ser utilizada isoladamente ou como m?todo complementar ? espirometria. Na nossa amostra as medidas de resist?ncia foram as que tiveram melhor performance de discrimina??o.Submitted by PPG Pediatria e Sa?de da Crian?a (pediatria-pg@pucrs.br) on 2020-01-20T18:04:04Z No. of bitstreams: 1 Tese Morgana vers?o final p?s banca.pdf: 2572773 bytes, checksum: 18b553626ae506b84ba17f1c19ec81c1 (MD5)Approved for entry into archive by Sheila Dias (sheila.dias@pucrs.br) on 2020-01-31T12:32:47Z (GMT) No. of bitstreams: 1 Tese Morgana vers?o final p?s banca.pdf: 2572773 bytes, checksum: 18b553626ae506b84ba17f1c19ec81c1 (MD5)Made available in DSpace on 2020-01-31T12:32:59Z (GMT). No. of bitstreams: 1 Tese Morgana vers?o final p?s banca.pdf: 2572773 bytes, checksum: 18b553626ae506b84ba17f1c19ec81c1 (MD5) Previous issue date: 2019-08-30Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - CAPESapplication/pdfhttp://tede2.pucrs.br:80/tede2/retrieve/177541/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.jpgporPontif?cia Universidade Cat?lica do Rio Grande do SulPrograma de P?s-Gradua??o em Medicina/Pediatria e Sa?de da Crian?aPUCRSBrasilEscola de Medicina1. Global Initiative For Asthma. Global Strategy for Asthma Management and Prevention; 2018. Available from: www.ginasthma.org. 2. Terzano C, Cremonesi G, Girbino G, Ingrassia E, Marsico S, Nicolini G, et al. 1-year prospective real life monitoring of asthma control and quality of life in Italy. Respiratory Research. 2012. 3. Braman SS. The global burden of asthma. In: Chest. 2006. 4. Pitrez PM, Stein RT. Asthma in Latin America: the dawn of a new epidemic. Current Opinion in Allergy and Clinical Immunology. 2008. 5. Wehrmeister FC, Menezes AMB, Cascaes AM, Mart?nez-Mesa J, Barros AJD. Time trend of asthma in children and adolescents in Brazil, 1998-2008. Rev Saude Publica. 2012; 6. Cardoso TDA, Roncada C, Rodrigues E, Pinto LA, Jones MH, Stein RT, et al. Impacto da asma no Brasil : an?lise longitudinal de dados extra?dos de um banco de dados governamental brasileiro. J Bras Pneumol. 2017; 7. Beasley R, Keil U, Von Mutius E, Pearce N. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998; 8. S?nchez-Cu?llar S, Berm?dez JA. El uso de los biomarcadores de inflamaci?n en la v?a a?rea en el manejo del asma. Revista de Patologia Respiratoria. 2012. 9. Kaminsky DA. What Does Airway Resistance Tell Us About Lung Function? Respir Care [Internet]. 2012 Jan 1 [cited 2016 Jan 25];57(1):85?99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22222128 10. V Vidal PC, Mattiello R, Jones MH, Herbert Jones M. Espirometria em Pr?-Escolares Spirometry in Preschool Children Endere?o para correspond?ncia. Vol. 22. 2013. 11. Allen JL. Input oscillometry and the forced oscillation technique for assessing lung function in preschool children with asthma. Pediatr Investig. 2018; 12. Chong Neto HJ, Sol? D, Camargos P, Ros?rio NA, Sarinho EC, Chong-Silva DC, et al. Diretrizes da Associa??o Brasileira de Alergia e Imunologia e Sociedade Brasileira de Pediatria para sibil?ncia e asma no pr?-escolar. Arq Asma, Alerg e Imunol. 2018; 13. Brashier B, Salvi S. Measuring lung function using sound waves: Role of the forced oscillation technique and impulse oscillometry system. Breathe [Internet]. 2015 Mar [cited 2015 Dec 28];11(1):57?65. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4487383&tool=pmcentrez&rendertype=abstract 14. Farr? R, Rotger M, Marchal F, Peslin R, Navajas D. Assessment of bronchial reactivity by forced oscillation admittance avoids the upper airway artefact. Eur Respir J [Internet]. 1999;13(4):761?6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10362037 15. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HGM, Aurora P, et al. An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary function testing in preschool children. American Journal of Respiratory and Critical Care Medicine. 2007. 16. Valle E. Resist?ncia das vias a?reas : t?cnica da oscila??o for?ada. J Pneumol. 2002; 17. De Assump??o MS, Gon?alves RM, Ferreira LG, Schivinski CIS. Sistema de oscilometria de impulso em pediatria: Revis?o de literatura. Medicina (Brazil). 2014. 18. Cz?vek D, Shackleton C, Hantos Z, Taylor K, Kumar A, Chacko A, et al. Tidal changes in respiratory resistance are sensitive indicators of airway obstruction in children. Thorax [Internet]. 2016 Oct [cited 2019 Aug 4];71(10):907?15. Available from: http://thorax.bmj.com/lookup/doi/10.1136/thoraxjnl-2015-208182 19. Bates JHT, Irvin CG, Farr? R, Hantos Z. Oscillation mechanics of the respiratory system. Compr Physiol [Internet]. 2011 [cited 2018 Dec 1];1(3):1233?72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22011237 20. Gray D, Cz??vek D, Smith E, Willemse L, Alberts A, Gingl Z, et al. Respiratory impedance in healthy unsedated South African infants: Effects of maternal smoking. Respirology [Internet]. 2015 Apr [cited 2016 Jan 24];20(3):467?73. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4670479&tool=pmcentrez&rendertype=abstract 21. Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J [Internet]. 2003;22(6):1026?41. Available from: http://erj.ersjournals.com/cgi/doi/10.1183/09031936.03.00089403 22. Sly PD, Hayden MJ, Pet?k F, Hantos Z, Sly PD Petak F, Hantos Z HMJ. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med [Internet]. 1996;154(1):161?6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8680673 23. Sly PD, Hayden MJ, Pet?k F, Hantos Z. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med [Internet]. 1996;154(1):161?6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8680673 24. Lambrecht, B. N., & Hammad, H. (2015). The immunology of asthma. Nature immunology, 16(1), 45.25. F?rum Internacional de Sociedades Respirat?rias. O Impacto Global da Doen?a Respirat?ria. European Respiratory Society. 2017. 26. Vasconcelos MM, Accioly LS, Le?o MJCC, Lima DST, Aguiar Filho AS, Lopes Neto EPA, et al. Conceitos de asma e instrumentos de levantamentos epidemiol?gicos de preval?ncia. Rev Port Pneumol. 2015; 27. Wallace J, Denk C, Kruse L. PEER REVIEWED: Pediatric Hospitalizations for Asthma: Use of a Linked File to Separate Person-level Risk and Readmission. Prev Chronic Dis. 2004; 28. Cookson W. The alliance of genes and environment in asthma and allergy. Nature. 2002; 29. Busse WW, Lemanske Jr. RF. Asthma. N Engl J Med. 2001; 30. Fleming L, Murray C, Bansal AT, Hashimoto S, Bisgaard H, Bush A, et al. The burden of severe asthma in childhood and adolescence: Results from the paediatric U-BIOPRED cohorts. In: European Respiratory Journal. 2015. 31. Gray D, Willemse L, Visagie A, Cz?vek D, Nduru P, Vanker A, et al. Determinants of early-life lung function in African infants. Thorax. 2016; 32. Malmberg LP, Pelkonen a, Poussa T, Pohianpalo a, Haahtela T, Turpeinen M. Determinants of respiratory system input impedance and bronchodilator response in healthy Finnish preschool children. Clin Physiol Funct Imaging [Internet]. 2002 Jan [cited 2016 Jan 6];22(1):64?71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12003103 33. Hall GL, Hantos Z, Petak F, Wildhaber JH, Tiller K, Burton PR, et al. Airway and respiratory tissue mechanics in normal infants. Am J Respir Crit Care Med [Internet]. 2000;162(4 I):1397?402. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11029351 34. Sole D, Aranda CS, Wandalsen GF. Asthma: epidemiology of disease control in Latin America - short review. Asthma Res Pr [Internet]. 2017/05/17. 2017;3:4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28507765 35. Sol? D, Wandalsen GF, Camelo-Nunes IC, Naspitz CK, Group I-B. Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3. J Pediatr (Rio J). 2006; 36. Sole D, Camelo-Nunes IC, Wandalsen GF, Mallozi MC. Asthma in children and adolescents in Brazil: contribution of the International Study of Asthma and Allergies in Childhood (ISAAC). Rev Paul Pediatr. 2014; 37. Roncada C, de Oliveira SG, Cidade SF. et al. Burden of asthma among inner-city children from Southern Brazil. J Asthma. 2016; 38. Campos HS. Asma: suas origens, seus mecanismos inflamat?rios e o papel do corticoster?ide. Rev Bras Pneumol Sanit?ria. 2007; 39. Holgate ST. Pathogenesis of Asthma. In: Allergy and Allergic Diseases, Second Edition. 2009. 40. V Kumar, Jon C. Aster AA. Robbins & Cotran Patologia - Bases Patol?gicas das Doen?as. Elsevier Brasil. 2015. 41. Mart?nez Aguilar NE. [Pathogenesis, trigger and risk factors in asthma]. Rev Alerg Mex. 2009; 42. Cockcroft DW. Direct challenge tests: Airway hyperresponsiveness in asthma: Its measurement and clinical significance. Chest. 2010. 43. Diagn?stico cl?nico e funcional da asma br?nquica. Rev Assoc Med Bras. 2004; 44. Souza-Machado C, Souza-Machado A, Franco R, Ponte E V., Barreto ML, Rodrigues LC, et al. Rapid reduction in hospitalisations after an intervention to manage severe asthma. Eur Respir J. 2010; 45. Juniper EF, O?Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999; 46. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the Asthma Control Test: A survey for assessing asthma control. J Allergy Clin Immunol. 2004; 47. LeBlanc A, Robichaud P, Lacasse Y, Boulet LP. Quantification of asthma control: Validation of the Asthma Control Scoring System. Allergy Eur J Allergy Clin Immunol. 2007; 48. Using beta 2-stimulants in asthma. Drug Ther Bull [Internet]. 1997 Jan [cited 2019 Aug 9];35(1):1?4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9282409 49. Adams, N, Bestall, J, Malouf R, et al. Beclomethasone versus placebo for chronic asthma ( Review ). Cochrane. 2008; 50. O?Byrne PM, Reddel HK, Eriksson G, ?stlund O, Peterson S, Sears MR, et al. Measuring asthma control: A comparison of three classification systems. Eur Respir J. 2010; 51. Barnes NC, Miller CJ. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: An integrated analysis of zafirlukast trials. Thorax. 2000; 52. Drazen JM, Israel E, O?Byrne PM. Treatment of Asthma with Drugs Modifying the Leukotriene Pathway. Surv Anesthesiol. 1999; 53. Bleecker ER, Welch MJ, Weinstein SF, Kalberg C, Johnson M, Edwards L, et al. Low-dose inhaled fluticasone propionate versus oral zaf irlukast in the treatment of persistent asthma. J Allergy Clin Immunol. 2000; 54. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma: An evidence-based approach. Med J Aust. 2003; 55. Diamant Z, Vijverberg S, Alving K, Bakirtas A, Bjermer L, Custovic A, et al. Towards clinically applicable biomarkers for asthma ? An EAACI position paper . Allergy. 2019; 56. Boyman O, Kaegi C, Akdis M, Bavbek S, Bossios A, Chatzipetrou A, et al. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy: European Journal of Allergy and Clinical Immunology. 2015. 57. Hekking PP, Loza MJ, Pavlidis S, de Meulder B, Lefaudeux D, Baribaud F, et al. Pathway discovery using transcriptomic profiles in adult-onset severe asthma. J Allergy Clin Immunol. 2018; 58. Hekking PP, Loza MJ, Pavlidis S, De Meulder B, Lefaudeux D, Baribaud F, et al. Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma. Eur Respir J. 2017; 59. Zissler UM, Esser-Von Bieren J, Jakwerth CA, Chaker AM, Schmidt-Weber CB. Current and future biomarkers in allergic asthma. Allergy: European Journal of Allergy and Clinical Immunology. 2016. 60. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med [Internet]. 2009/06/02. 2009;180(5):388?95. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19483109 61. Reis AP dos, Machado JAN. Biomarcadores e imunobiol?gicos na asma. Brazilian J Allergy Immunol. 2019; 62. Almstrand AC, Ljungstrom E, Lausmaa, J. et al. Airway monitoring by collection and mass spectrometric analysis of exhaled particles. Analytical Chemistry. 2009. 63. Trivedi A, Hall C, Hoffman EA, Woods JC, Gierada DS. Clinical reviews in allergy and immunology Using imaging as a biomarker for asthma. J Allergy Clin Immunol. 2017; 64. Normansell R, Walker S, Milan SJ, Walters EH, P. N. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;13(1):1?109. 65. Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, et al. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma. N Engl J Med. 2014; 66. Nair P, Pizzichini MMM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, et al. Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia. N Engl J Med. 2009; 67. Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, et al. Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma. N Engl J Med. 2014; 68. Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, et al. Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial. Lancet. 2012; 69. Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: Results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med. 2015; 70. Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M. Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study. In: Chest. 2016. 71. Castro M, Wenzel, SE. Bleecker ER. et al. Benralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: A phase 2b randomised dose-ranging study. The Lancet Respiratory Medicine. 2014. 72. Pereira CAC. Espirometria. J Pneumol . 2002;28. 73. Cruz AA, Fernandes AL, Pizzichini E, Fiterman J, Pereira LF, Pizzichini M, et al. Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o Manejo da Asma - 2012. J Bras Pneumol 2012. 38:S1-46. 74. Pereira CADC. CONSENSO DE Espirometria. J Bras Pneumol. 2002; 75. Burity EF, Pereira CA de C, Rizzo J?, Sarinho ESC, Jones MH. Efeito da termina??o precoce da expira??o nos par?metros espirom?tricos em crian?as pr?-escolares saud?veis. J Bras Pneumol. 2011; 76. Fran?a DC, Camargos PAM, Jones MH, Martins JA, Vieira B da SPP, Colosimo EA, et al. Prediction equations for spirometry in four? to six?year?old children. J Pediatr (Vers?o em Port. 2016; 77. Kaminsky DA. What Does Airway Resistance Tell Us About Lung Function? Respir Care [Internet]. 2012 Jan 1 [cited 2016 Jan 25];57(1):85?99. Available from: http://rc.rcjournal.com/cgi/doi/10.4187/respcare.01411 78. MacLeod D, Birch M. Respiratory input impedance measurement: Forced oscillation methods. Medical and Biological Engineering and Computing. 2001. 79. Sly PD, Hayden MJ, Pet?k F, Hantos Z. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med. 1996; 80. Bates JHT. Systems physiology of the airways in health and obstructive pulmonary disease. Wiley Interdiscip Rev Syst Biol Med. 2016; 81. Melo PL. Forced oscillation technique in pulmonology practice: principles and examples of potential applications. Pulm?o RJ. 2015;24(1):42-48. 82. Shirai T, Kurosawa H. Clinical Application of the Forced Oscillation Technique. Intern Med [Internet]. 2016;55(6):559?66. Available from: https://www.jstage.jst.go.jp/article/internalmedicine/55/6/55_55.5876/_article 83. Johnson MK, Birch M, Carter R, et al. Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry. Thorax 2007; 62: 299?306. 84. Lorx A, Czovek D, Gingl Z, Makan G, Radics B, Bartusek D, et al. Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure. Eur Respir J [Internet]. 2017/02/17. 2017;49(2). Available from: https://www.ncbi.nlm.nih.gov/pubmed/28202552 85. Silva KKD da, Faria ACD, Lopes AJ, Melo PL de. Within-breath respiratory impedance and airway obstruction in patients with chronic obstructive pulmonary disease. Clin (S?o Paulo, Brazil) [Internet]. 2015 Jul [cited 2016 Jan 28];70(7):461?9. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4496751&tool=pmcentrez&rendertype=abstract 86. Davidson RN Hussain A, Saunders KB GCA. Within-breath changes of airway calibre in patients with airflow obstruction by continuous measurement of respiratory impedance. Br J Dis Chest. 1986;80(4):335?52. 87. Veras TN, Pinto LA. Viabilidade da realiza??o de espirometria em pr?-escolares. J Bras Pneumol. 2011; 88. World Health Organization. Growth reference data for 5-19 years. Who Child Growth Stand. 2013; 89. de Onis M, Garza C, Onyango AW, Borghi E. Comparison of the WHO Child Growth Standards and the CDC 2000 Growth Charts. J Nutr. 2007; 90. Brasil. Resolu??o No 466, de 12 de dezembro de 2012. Di?rio of da Uni?o. 2012;557290555552975733500500500600600600-224747486637135387-969369452308786627-7702826533010964327-80674179539253457523590462550136975366T?cnica de Oscila??es For?adasTeste de Fun??o PulmonarImped?ncia Respirat?riaCrian?aAsmaForced Oscillation TechniqueRespiratory Function TestsRespiratory MechanicsChildAsthmaCIENCIAS DA SAUDE::MEDICINACIENCIAS DA SAUDE::ENFERMAGEMMEDICINA::SAUDE MATERNO-INFANTILAcur?cia das medidas de imped?ncia respirat?ria para o diagn?stico de asma em crian?asinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisTrabalho ser? publicado como artigo ou livro60 meses31/01/2025info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da PUC_RSinstname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)instacron:PUC_RSTHUMBNAILTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.jpgTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.jpgimage/jpeg4087http://tede2.pucrs.br/tede2/bitstream/tede/9081/4/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.jpg986ee145064af681f7777c316248e20cMD54TEXTTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.txtTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.txttext/plain1698http://tede2.pucrs.br/tede2/bitstream/tede/9081/3/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.txtd16dc4aa8644cd0d4df8d4e5068696e0MD53ORIGINALTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdfTES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdfapplication/pdf705739http://tede2.pucrs.br/tede2/bitstream/tede/9081/2/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf35ffca4b472da18ca6d4d8fd09c9906fMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-8590http://tede2.pucrs.br/tede2/bitstream/tede/9081/1/license.txt220e11f2d3ba5354f917c7035aadef24MD51tede/90812020-01-31 12:00:14.138oai:tede2.pucrs.br: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Biblioteca Digital de Teses e Dissertaçõeshttp://tede2.pucrs.br/tede2/PRIhttps://tede2.pucrs.br/oai/requestbiblioteca.central@pucrs.br||opendoar:2020-01-31T14:00:14Biblioteca Digital de Teses e Dissertações da PUC_RS - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)false
dc.title.por.fl_str_mv Acur?cia das medidas de imped?ncia respirat?ria para o diagn?stico de asma em crian?as
title Acur?cia das medidas de imped?ncia respirat?ria para o diagn?stico de asma em crian?as
spellingShingle Acur?cia das medidas de imped?ncia respirat?ria para o diagn?stico de asma em crian?as
Fernandes, Morgana Tha?s Carollo
T?cnica de Oscila??es For?adas
Teste de Fun??o Pulmonar
Imped?ncia Respirat?ria
Crian?a
Asma
Forced Oscillation Technique
Respiratory Function Tests
Respiratory Mechanics
Child
Asthma
CIENCIAS DA SAUDE::MEDICINA
CIENCIAS DA SAUDE::ENFERMAGEM
MEDICINA::SAUDE MATERNO-INFANTIL
title_short Acur?cia das medidas de imped?ncia respirat?ria para o diagn?stico de asma em crian?as
title_full Acur?cia das medidas de imped?ncia respirat?ria para o diagn?stico de asma em crian?as
title_fullStr Acur?cia das medidas de imped?ncia respirat?ria para o diagn?stico de asma em crian?as
title_full_unstemmed Acur?cia das medidas de imped?ncia respirat?ria para o diagn?stico de asma em crian?as
title_sort Acur?cia das medidas de imped?ncia respirat?ria para o diagn?stico de asma em crian?as
author Fernandes, Morgana Tha?s Carollo
author_facet Fernandes, Morgana Tha?s Carollo
author_role author
dc.contributor.advisor1.fl_str_mv Jones, Marcus Herbert
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/2057491798074403
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/7890106575135063
dc.contributor.author.fl_str_mv Fernandes, Morgana Tha?s Carollo
contributor_str_mv Jones, Marcus Herbert
dc.subject.por.fl_str_mv T?cnica de Oscila??es For?adas
Teste de Fun??o Pulmonar
Imped?ncia Respirat?ria
Crian?a
Asma
topic T?cnica de Oscila??es For?adas
Teste de Fun??o Pulmonar
Imped?ncia Respirat?ria
Crian?a
Asma
Forced Oscillation Technique
Respiratory Function Tests
Respiratory Mechanics
Child
Asthma
CIENCIAS DA SAUDE::MEDICINA
CIENCIAS DA SAUDE::ENFERMAGEM
MEDICINA::SAUDE MATERNO-INFANTIL
dc.subject.eng.fl_str_mv Forced Oscillation Technique
Respiratory Function Tests
Respiratory Mechanics
Child
Asthma
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE::MEDICINA
CIENCIAS DA SAUDE::ENFERMAGEM
MEDICINA::SAUDE MATERNO-INFANTIL
description Introduction: Detecting airway changes is very important for treatment and diagnosis of asthmatic children. For the efficient and cost-effective adoption of treatment options directed at daily clinical practice, reliable and well-defined biomarkers contribute to the identification of asthma phenotypes and endotypes that are most likely to respond. In this scenario, the forced oscillation technique (FOT) is a promising method in the diagnosis and monitoring of respiratory diseases. Objective: To evidence forced oscillation technique (FOT) parameters that may be used as biomarkers for the diagnosis and monitoring of asthma. Methods: cross-sectional observational study with a quantitative approach. The sample consisted of children and adolescents with asthma and healthy controls, aged 3 to 17 years old, recruited from the S?o Lucas Hospital of the Pontifical Catholic University of Rio Grande do Sul (PUCRS). The anthropometry, clinical history and respiratory impedance measurements were obtained in all participants. The Research Ethics Committee of the educational institution under opinion No. 3,100,553 approved the project and informed consent was obtained from all participants and their guardians. Results: A total of 101 individuals (61 males) were recruited, 38 with asthma (Asthma group) and 63 healthy controls (Control group). Pre-bronchodilator spectral measurements showed that all variables had significant differences (p <0.001), with higher resistance and lower (negative) reactance in the asthmatic group. In the within-breath analysis, we observed that in the measurements taken before bronchodilator administration, the differences were significant between the two groups, with p?0.001 in all comparisons except in the difference between mean inspiratory resistance and expiration (dRmean). The accuracy of resistance measures to discriminate asthma was 0.94 for ReE, 0.89 for ReI and 0.76 for ReE-ReI and for reactance was 0.91 for XeE, 0.91 for XeI and 0.79 to XeE-XeI. Correcting estimates of accuracy, sensitivity, specificity, and area under the curve by confounders (stature) on the ROC curve did not change the results. Conclusions: The data obtained suggest that within-breath FOT measurements have excellent discriminatory power for asthma in children and adolescents. Measurement of impedance may aid in the diagnosis of asthma, may also assess the effect of treatment on pulmonary function, and may be used alone or as a complementary method to spirometry. In our sample, the resistance measures had the best discrimination performance.
publishDate 2019
dc.date.issued.fl_str_mv 2019-08-30
dc.date.accessioned.fl_str_mv 2020-01-31T12:32:59Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://tede2.pucrs.br/tede2/handle/tede/9081
url http://tede2.pucrs.br/tede2/handle/tede/9081
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv 557290555552975733
dc.relation.confidence.fl_str_mv 500
500
500
600
600
600
dc.relation.department.fl_str_mv -224747486637135387
dc.relation.cnpq.fl_str_mv -969369452308786627
-7702826533010964327
-8067417953925345752
dc.relation.sponsorship.fl_str_mv 3590462550136975366
dc.relation.references.por.fl_str_mv 1. Global Initiative For Asthma. Global Strategy for Asthma Management and Prevention; 2018. Available from: www.ginasthma.org. 2. Terzano C, Cremonesi G, Girbino G, Ingrassia E, Marsico S, Nicolini G, et al. 1-year prospective real life monitoring of asthma control and quality of life in Italy. Respiratory Research. 2012. 3. Braman SS. The global burden of asthma. In: Chest. 2006. 4. Pitrez PM, Stein RT. Asthma in Latin America: the dawn of a new epidemic. Current Opinion in Allergy and Clinical Immunology. 2008. 5. Wehrmeister FC, Menezes AMB, Cascaes AM, Mart?nez-Mesa J, Barros AJD. Time trend of asthma in children and adolescents in Brazil, 1998-2008. Rev Saude Publica. 2012; 6. Cardoso TDA, Roncada C, Rodrigues E, Pinto LA, Jones MH, Stein RT, et al. Impacto da asma no Brasil : an?lise longitudinal de dados extra?dos de um banco de dados governamental brasileiro. J Bras Pneumol. 2017; 7. Beasley R, Keil U, Von Mutius E, Pearce N. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998; 8. S?nchez-Cu?llar S, Berm?dez JA. El uso de los biomarcadores de inflamaci?n en la v?a a?rea en el manejo del asma. Revista de Patologia Respiratoria. 2012. 9. Kaminsky DA. What Does Airway Resistance Tell Us About Lung Function? Respir Care [Internet]. 2012 Jan 1 [cited 2016 Jan 25];57(1):85?99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22222128 10. V Vidal PC, Mattiello R, Jones MH, Herbert Jones M. Espirometria em Pr?-Escolares Spirometry in Preschool Children Endere?o para correspond?ncia. Vol. 22. 2013. 11. Allen JL. Input oscillometry and the forced oscillation technique for assessing lung function in preschool children with asthma. Pediatr Investig. 2018; 12. Chong Neto HJ, Sol? D, Camargos P, Ros?rio NA, Sarinho EC, Chong-Silva DC, et al. Diretrizes da Associa??o Brasileira de Alergia e Imunologia e Sociedade Brasileira de Pediatria para sibil?ncia e asma no pr?-escolar. Arq Asma, Alerg e Imunol. 2018; 13. Brashier B, Salvi S. Measuring lung function using sound waves: Role of the forced oscillation technique and impulse oscillometry system. Breathe [Internet]. 2015 Mar [cited 2015 Dec 28];11(1):57?65. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4487383&tool=pmcentrez&rendertype=abstract 14. Farr? R, Rotger M, Marchal F, Peslin R, Navajas D. Assessment of bronchial reactivity by forced oscillation admittance avoids the upper airway artefact. Eur Respir J [Internet]. 1999;13(4):761?6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10362037 15. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HGM, Aurora P, et al. An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary function testing in preschool children. American Journal of Respiratory and Critical Care Medicine. 2007. 16. Valle E. Resist?ncia das vias a?reas : t?cnica da oscila??o for?ada. J Pneumol. 2002; 17. De Assump??o MS, Gon?alves RM, Ferreira LG, Schivinski CIS. Sistema de oscilometria de impulso em pediatria: Revis?o de literatura. Medicina (Brazil). 2014. 18. Cz?vek D, Shackleton C, Hantos Z, Taylor K, Kumar A, Chacko A, et al. Tidal changes in respiratory resistance are sensitive indicators of airway obstruction in children. Thorax [Internet]. 2016 Oct [cited 2019 Aug 4];71(10):907?15. Available from: http://thorax.bmj.com/lookup/doi/10.1136/thoraxjnl-2015-208182 19. Bates JHT, Irvin CG, Farr? R, Hantos Z. Oscillation mechanics of the respiratory system. Compr Physiol [Internet]. 2011 [cited 2018 Dec 1];1(3):1233?72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22011237 20. Gray D, Cz??vek D, Smith E, Willemse L, Alberts A, Gingl Z, et al. Respiratory impedance in healthy unsedated South African infants: Effects of maternal smoking. Respirology [Internet]. 2015 Apr [cited 2016 Jan 24];20(3):467?73. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4670479&tool=pmcentrez&rendertype=abstract 21. Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J [Internet]. 2003;22(6):1026?41. Available from: http://erj.ersjournals.com/cgi/doi/10.1183/09031936.03.00089403 22. Sly PD, Hayden MJ, Pet?k F, Hantos Z, Sly PD Petak F, Hantos Z HMJ. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med [Internet]. 1996;154(1):161?6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8680673 23. Sly PD, Hayden MJ, Pet?k F, Hantos Z. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med [Internet]. 1996;154(1):161?6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8680673 24. Lambrecht, B. N., & Hammad, H. (2015). The immunology of asthma. Nature immunology, 16(1), 45.25. F?rum Internacional de Sociedades Respirat?rias. O Impacto Global da Doen?a Respirat?ria. European Respiratory Society. 2017. 26. Vasconcelos MM, Accioly LS, Le?o MJCC, Lima DST, Aguiar Filho AS, Lopes Neto EPA, et al. Conceitos de asma e instrumentos de levantamentos epidemiol?gicos de preval?ncia. Rev Port Pneumol. 2015; 27. Wallace J, Denk C, Kruse L. PEER REVIEWED: Pediatric Hospitalizations for Asthma: Use of a Linked File to Separate Person-level Risk and Readmission. Prev Chronic Dis. 2004; 28. Cookson W. The alliance of genes and environment in asthma and allergy. Nature. 2002; 29. Busse WW, Lemanske Jr. RF. Asthma. N Engl J Med. 2001; 30. Fleming L, Murray C, Bansal AT, Hashimoto S, Bisgaard H, Bush A, et al. The burden of severe asthma in childhood and adolescence: Results from the paediatric U-BIOPRED cohorts. In: European Respiratory Journal. 2015. 31. Gray D, Willemse L, Visagie A, Cz?vek D, Nduru P, Vanker A, et al. Determinants of early-life lung function in African infants. Thorax. 2016; 32. Malmberg LP, Pelkonen a, Poussa T, Pohianpalo a, Haahtela T, Turpeinen M. Determinants of respiratory system input impedance and bronchodilator response in healthy Finnish preschool children. Clin Physiol Funct Imaging [Internet]. 2002 Jan [cited 2016 Jan 6];22(1):64?71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12003103 33. Hall GL, Hantos Z, Petak F, Wildhaber JH, Tiller K, Burton PR, et al. Airway and respiratory tissue mechanics in normal infants. Am J Respir Crit Care Med [Internet]. 2000;162(4 I):1397?402. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11029351 34. Sole D, Aranda CS, Wandalsen GF. Asthma: epidemiology of disease control in Latin America - short review. Asthma Res Pr [Internet]. 2017/05/17. 2017;3:4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28507765 35. Sol? D, Wandalsen GF, Camelo-Nunes IC, Naspitz CK, Group I-B. Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3. J Pediatr (Rio J). 2006; 36. Sole D, Camelo-Nunes IC, Wandalsen GF, Mallozi MC. Asthma in children and adolescents in Brazil: contribution of the International Study of Asthma and Allergies in Childhood (ISAAC). Rev Paul Pediatr. 2014; 37. Roncada C, de Oliveira SG, Cidade SF. et al. Burden of asthma among inner-city children from Southern Brazil. J Asthma. 2016; 38. Campos HS. Asma: suas origens, seus mecanismos inflamat?rios e o papel do corticoster?ide. Rev Bras Pneumol Sanit?ria. 2007; 39. Holgate ST. Pathogenesis of Asthma. In: Allergy and Allergic Diseases, Second Edition. 2009. 40. V Kumar, Jon C. Aster AA. Robbins & Cotran Patologia - Bases Patol?gicas das Doen?as. Elsevier Brasil. 2015. 41. Mart?nez Aguilar NE. [Pathogenesis, trigger and risk factors in asthma]. Rev Alerg Mex. 2009; 42. Cockcroft DW. Direct challenge tests: Airway hyperresponsiveness in asthma: Its measurement and clinical significance. Chest. 2010. 43. Diagn?stico cl?nico e funcional da asma br?nquica. Rev Assoc Med Bras. 2004; 44. Souza-Machado C, Souza-Machado A, Franco R, Ponte E V., Barreto ML, Rodrigues LC, et al. Rapid reduction in hospitalisations after an intervention to manage severe asthma. Eur Respir J. 2010; 45. Juniper EF, O?Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999; 46. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the Asthma Control Test: A survey for assessing asthma control. J Allergy Clin Immunol. 2004; 47. LeBlanc A, Robichaud P, Lacasse Y, Boulet LP. Quantification of asthma control: Validation of the Asthma Control Scoring System. Allergy Eur J Allergy Clin Immunol. 2007; 48. Using beta 2-stimulants in asthma. Drug Ther Bull [Internet]. 1997 Jan [cited 2019 Aug 9];35(1):1?4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9282409 49. Adams, N, Bestall, J, Malouf R, et al. Beclomethasone versus placebo for chronic asthma ( Review ). Cochrane. 2008; 50. O?Byrne PM, Reddel HK, Eriksson G, ?stlund O, Peterson S, Sears MR, et al. Measuring asthma control: A comparison of three classification systems. Eur Respir J. 2010; 51. Barnes NC, Miller CJ. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: An integrated analysis of zafirlukast trials. Thorax. 2000; 52. Drazen JM, Israel E, O?Byrne PM. Treatment of Asthma with Drugs Modifying the Leukotriene Pathway. Surv Anesthesiol. 1999; 53. Bleecker ER, Welch MJ, Weinstein SF, Kalberg C, Johnson M, Edwards L, et al. Low-dose inhaled fluticasone propionate versus oral zaf irlukast in the treatment of persistent asthma. J Allergy Clin Immunol. 2000; 54. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma: An evidence-based approach. Med J Aust. 2003; 55. Diamant Z, Vijverberg S, Alving K, Bakirtas A, Bjermer L, Custovic A, et al. Towards clinically applicable biomarkers for asthma ? An EAACI position paper . Allergy. 2019; 56. Boyman O, Kaegi C, Akdis M, Bavbek S, Bossios A, Chatzipetrou A, et al. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy: European Journal of Allergy and Clinical Immunology. 2015. 57. Hekking PP, Loza MJ, Pavlidis S, de Meulder B, Lefaudeux D, Baribaud F, et al. Pathway discovery using transcriptomic profiles in adult-onset severe asthma. J Allergy Clin Immunol. 2018; 58. Hekking PP, Loza MJ, Pavlidis S, De Meulder B, Lefaudeux D, Baribaud F, et al. Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma. Eur Respir J. 2017; 59. Zissler UM, Esser-Von Bieren J, Jakwerth CA, Chaker AM, Schmidt-Weber CB. Current and future biomarkers in allergic asthma. Allergy: European Journal of Allergy and Clinical Immunology. 2016. 60. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med [Internet]. 2009/06/02. 2009;180(5):388?95. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19483109 61. Reis AP dos, Machado JAN. Biomarcadores e imunobiol?gicos na asma. Brazilian J Allergy Immunol. 2019; 62. Almstrand AC, Ljungstrom E, Lausmaa, J. et al. Airway monitoring by collection and mass spectrometric analysis of exhaled particles. Analytical Chemistry. 2009. 63. Trivedi A, Hall C, Hoffman EA, Woods JC, Gierada DS. Clinical reviews in allergy and immunology Using imaging as a biomarker for asthma. J Allergy Clin Immunol. 2017; 64. Normansell R, Walker S, Milan SJ, Walters EH, P. N. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;13(1):1?109. 65. Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, et al. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma. N Engl J Med. 2014; 66. Nair P, Pizzichini MMM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, et al. Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia. N Engl J Med. 2009; 67. Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, et al. Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma. N Engl J Med. 2014; 68. Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, et al. Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial. Lancet. 2012; 69. Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: Results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med. 2015; 70. Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M. Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study. In: Chest. 2016. 71. Castro M, Wenzel, SE. Bleecker ER. et al. Benralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: A phase 2b randomised dose-ranging study. The Lancet Respiratory Medicine. 2014. 72. Pereira CAC. Espirometria. J Pneumol . 2002;28. 73. Cruz AA, Fernandes AL, Pizzichini E, Fiterman J, Pereira LF, Pizzichini M, et al. Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o Manejo da Asma - 2012. J Bras Pneumol 2012. 38:S1-46. 74. Pereira CADC. CONSENSO DE Espirometria. J Bras Pneumol. 2002; 75. Burity EF, Pereira CA de C, Rizzo J?, Sarinho ESC, Jones MH. Efeito da termina??o precoce da expira??o nos par?metros espirom?tricos em crian?as pr?-escolares saud?veis. J Bras Pneumol. 2011; 76. Fran?a DC, Camargos PAM, Jones MH, Martins JA, Vieira B da SPP, Colosimo EA, et al. Prediction equations for spirometry in four? to six?year?old children. J Pediatr (Vers?o em Port. 2016; 77. Kaminsky DA. What Does Airway Resistance Tell Us About Lung Function? Respir Care [Internet]. 2012 Jan 1 [cited 2016 Jan 25];57(1):85?99. Available from: http://rc.rcjournal.com/cgi/doi/10.4187/respcare.01411 78. MacLeod D, Birch M. Respiratory input impedance measurement: Forced oscillation methods. Medical and Biological Engineering and Computing. 2001. 79. Sly PD, Hayden MJ, Pet?k F, Hantos Z. Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med. 1996; 80. Bates JHT. Systems physiology of the airways in health and obstructive pulmonary disease. Wiley Interdiscip Rev Syst Biol Med. 2016; 81. Melo PL. Forced oscillation technique in pulmonology practice: principles and examples of potential applications. Pulm?o RJ. 2015;24(1):42-48. 82. Shirai T, Kurosawa H. Clinical Application of the Forced Oscillation Technique. Intern Med [Internet]. 2016;55(6):559?66. Available from: https://www.jstage.jst.go.jp/article/internalmedicine/55/6/55_55.5876/_article 83. Johnson MK, Birch M, Carter R, et al. Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry. Thorax 2007; 62: 299?306. 84. Lorx A, Czovek D, Gingl Z, Makan G, Radics B, Bartusek D, et al. Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure. Eur Respir J [Internet]. 2017/02/17. 2017;49(2). Available from: https://www.ncbi.nlm.nih.gov/pubmed/28202552 85. Silva KKD da, Faria ACD, Lopes AJ, Melo PL de. Within-breath respiratory impedance and airway obstruction in patients with chronic obstructive pulmonary disease. Clin (S?o Paulo, Brazil) [Internet]. 2015 Jul [cited 2016 Jan 28];70(7):461?9. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4496751&tool=pmcentrez&rendertype=abstract 86. Davidson RN Hussain A, Saunders KB GCA. Within-breath changes of airway calibre in patients with airflow obstruction by continuous measurement of respiratory impedance. Br J Dis Chest. 1986;80(4):335?52. 87. Veras TN, Pinto LA. Viabilidade da realiza??o de espirometria em pr?-escolares. J Bras Pneumol. 2011; 88. World Health Organization. Growth reference data for 5-19 years. Who Child Growth Stand. 2013; 89. de Onis M, Garza C, Onyango AW, Borghi E. Comparison of the WHO Child Growth Standards and the CDC 2000 Growth Charts. J Nutr. 2007; 90. Brasil. Resolu??o No 466, de 12 de dezembro de 2012. Di?rio of da Uni?o. 2012;
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Pontif?cia Universidade Cat?lica do Rio Grande do Sul
dc.publisher.program.fl_str_mv Programa de P?s-Gradua??o em Medicina/Pediatria e Sa?de da Crian?a
dc.publisher.initials.fl_str_mv PUCRS
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Escola de Medicina
publisher.none.fl_str_mv Pontif?cia Universidade Cat?lica do Rio Grande do Sul
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da PUC_RS
instname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron:PUC_RS
instname_str Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron_str PUC_RS
institution PUC_RS
reponame_str Biblioteca Digital de Teses e Dissertações da PUC_RS
collection Biblioteca Digital de Teses e Dissertações da PUC_RS
bitstream.url.fl_str_mv http://tede2.pucrs.br/tede2/bitstream/tede/9081/4/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.jpg
http://tede2.pucrs.br/tede2/bitstream/tede/9081/3/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf.txt
http://tede2.pucrs.br/tede2/bitstream/tede/9081/2/TES_MORGANA_THAIS_CAROLLO_FERNANDES_CONFIDENCIAL.pdf
http://tede2.pucrs.br/tede2/bitstream/tede/9081/1/license.txt
bitstream.checksum.fl_str_mv 986ee145064af681f7777c316248e20c
d16dc4aa8644cd0d4df8d4e5068696e0
35ffca4b472da18ca6d4d8fd09c9906f
220e11f2d3ba5354f917c7035aadef24
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da PUC_RS - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
repository.mail.fl_str_mv biblioteca.central@pucrs.br||
_version_ 1796793242928283648